skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines pomalidomideQuestion & answer

pomalidomide · Medicine question

Is pomalidomide used for multiple myeloma in children aged 0–17 years?

iatroX medicinesPublished 8 November 2026

The answer

Answer

There is no relevant use of pomalidomide for multiple myeloma in children aged 0–17 years.

Sources for this answer

Pomalidomide Zentiva 1mg hard capsZentiva · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated 12 December 2024

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about pomalidomide

How should the Zentiva product's pomalidomide hard capsules be removed from the blister to reduce the risk of damage?When should pomalidomide be taken on haemodialysis days?Which named strong CYP1A2 inhibitors interact with pomalidomide?Which severe skin reactions are listed in the safety guidance for pomalidomide?For which adults with relapsed and refractory multiple myeloma is Pomalidomide Zentiva with dexamethasone indicated?Which adults with multiple myeloma are eligible for Pomalidomide Zentiva in combination with bortezomib and dexamethasone?

pomalidomide

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the pomalidomide guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX